Zymosan [Immunological Reagent]

Rebamipide an amino acid derivative of 2-(1H)-quinolinone is used for mucosal protection healing of gastroduodenal ulcers and treatment of gastritis. It works by enhancing mucosal defense scavenging free radicals and temporarily activating genes encoding cyclooxygenase-2.

For R&D use onlynot for drug household or other uses.

Rebamipide is used in a number of Asian countries including Japan (marketed as Mucosta) South Korea China and India (where it is marketed under the trade name Rebagen). It is not approved by the Food and Drug Administration for use in the United States.